We’re honored to present an exclusive dialogue featuring Professor Julien Calderaro, President of the 2025 EASL Liver Cancer Summit, and Professor Jian Zhou from Zhongshan Hospital, Fudan University and the President of the Asia-Pacific Primary Liver Cancer Expert Alliance (APPLE).
Together, they explore the current challenges in hepatocellular carcinoma (HCC) treatment, and share insights into breakthrough directions in liver cancer diagnosis and therapy.
This in-depth exchange marked a pivotal moment in global liver cancer collaboration, showcasing the synergy of expert perspectives from both Europe and Asia.
